Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07477405
Eligibility Criteria:
Inclusion Criteria:
1. Patient over the age of 18 years, undergoing PCI with at least one DCB attempted.
2. Patient has provided written informed consent as approved by the Ethics Committee (EC)
3. Patient is willing to undergo all registry procedures and follow-up requirements
Exclusion Criteria:
1. Patients with known allergy to antiplatelet drugs or DCB antiproliferative agents
2. Life expectancy less than 12 months
3. Cardiogenic shock
4. Left ventricular ejection fraction \< 15%.
5. Any condition, which in the investigator opinion, would preclude safe participation of the patient in the registry.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07477405
Study Brief:
Protocol Section:
NCT07477405